Aggressive pituitary tumours and pituitary carcinomas

G Raverot, MD Ilie, H Lasolle, V Amodru… - Nature Reviews …, 2021 - nature.com
Although usually benign, anterior pituitary tumours occasionally exhibit aggressive
behaviour, with invasion of surrounding tissues, rapid growth, resistance to conventional …

Aggressive pituitary adenomas—diagnosis and emerging treatments

A Di Ieva, F Rotondo, LV Syro, MD Cusimano… - Nature Reviews …, 2014 - nature.com
The WHO categorizes pituitary tumours as typical adenomas, atypical adenomas and
pituitary carcinomas, with typical adenomas constituting the major class. However, the WHO …

NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink

OA Ulanovskaya, AM Zuhl, BF Cravatt - Nature chemical biology, 2013 - nature.com
Nicotinamide N-methyltransferase (NNMT) is overexpressed in a variety of human cancers,
where it contributes to tumorigenesis by a mechanism that is still poorly understood. Here …

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

J Trouillas, P Roy, N Sturm, E Dantony… - Acta …, 2013 - Springer
Pituitary adenomas are currently classified by histological, immunocytochemical and
numerous ultrastructural characteristics lacking unequivocal prognostic correlations. We …

Mitotic chromosomal instability and cancer: mouse modelling of the human disease

JM Schvartzman, R Sotillo, R Benezra - Nature Reviews Cancer, 2010 - nature.com
The stepwise progression from an early dysplastic lesion to full-blown metastatic malignancy
is associated with increases in genomic instability. Mitotic chromosomal instability—the …

Epidemiology and etiopathogenesis of pituitary adenomas

ED Aflorei, M Korbonits - Journal of neuro-oncology, 2014 - Springer
Pituitary adenomas are usually benign monoclonal tumours presenting either due to
hypersecretion of pituitary hormones, and/or due to local space occupying effects and …

Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients

L Vroonen, ML Jaffrain-Rea… - European journal of …, 2012 - academic.oup.com
Background Dopamine agonist resistance in prolactinoma is an infrequent phenomenon.
Doses of cabergoline (CAB) of up to 2.0 mg/week are usually effective in controlling …

[HTML][HTML] Biomarkers of aggressive pituitary adenomas

O Mete, S Ezzat, SL Asa - Journal of molecular endocrinology, 2012 - jme.bioscientifica.com
Pituitary adenomas exhibit a wide range of behaviors. The prediction of aggressive or
malignant behavior in pituitary adenomas remains challenging; however, the utility of …

Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care …

S Asioli, A Righi, M Iommi, C Baldovini… - European journal of …, 2019 - academic.oup.com
Objective and design A clinicopathological score has been proposed by Trouillas et al. to
predict the evolution of pituitary adenomas. Aim of our study was to perform an independent …

Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up

G Raverot, A Wierinckx, E Dantony… - The Journal of …, 2010 - academic.oup.com
Abstract Context and Objective: Predicting pituitary tumor behavior remains a challenge.
This multiparameter investigation aimed to identify markers for recurrence and progression …